EPICRISPR BIOTECHNOLOGIES Trademark
Trademark Overview
On Wednesday, August 9, 2023, a trademark application was filed for EPICRISPR BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the EPICRISPR BIOTECHNOLOGIES trademark a serial number of 98125106. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Tuesday, August 13, 2024. This trademark is owned by Epicrispr Biotechnologies, Inc.. The EPICRISPR BIOTECHNOLOGIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; provision of medical research and scientific research information in the field of gene regulation and epigenetics and the use of crispr technology in relation thereto
General Information
| Serial Number | 98125106 |
| Word Mark | EPICRISPR BIOTECHNOLOGIES |
| Filing Date | Wednesday, August 9, 2023 |
| Status | 616 - REVIVED - AWAITING FURTHER ACTION |
| Status Date | Tuesday, August 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the term "EPICRISPR" over the term "BIOTECHNOLOGIES" with a triangle dotting each of the letter "i" in "EPICRISPR" and a cascade of dots starting over the first letter "p" and ending under the second letter "p" of "EPICRISPR.". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; provision of medical research and scientific research information in the field of gene regulation and epigenetics and the use of crispr technology in relation thereto |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Epicrispr Biotechnologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
Trademark Events
| Event Date | Event Description |
| Sunday, September 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, August 12, 2023 | NEW APPLICATION ENTERED |
| Tuesday, April 9, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 16, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 16, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 31, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, July 31, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, August 13, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, August 13, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, August 13, 2024 | PETITION TO REVIVE-GRANTED |
| Tuesday, August 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
